These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1312085)

  • 41. Enhanced production of pituitary adenylate-cyclase-activating polypeptide by 1, N6-dibutyryladenosine 3',5'-monophosphate, phorbol 12-myristate 13-acetate and by the polypeptide itself in human neuroblastoma cells, IMR-32.
    Suzuki N; Harada M; Hosoya M; Fujino M
    Eur J Biochem; 1994 Jul; 223(1):147-53. PubMed ID: 7913440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pituitary adenylate cyclase-activating polypeptide causes Ca2+ release from ryanodine/caffeine stores through a novel pathway independent of both inositol trisphosphates and cyclic AMP in bovine adrenal medullary cells.
    Tanaka K; Shibuya I; Uezono Y; Ueta Y; Toyohira Y; Yanagihara N; Izumi F; Kanno T; Yamashita H
    J Neurochem; 1998 Apr; 70(4):1652-61. PubMed ID: 9523583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. A novel VIP-independent action of PHI via MAP kinase.
    Lelièvre V; Pineau N; Du J; Wen CH; Nguyen T; Janet T; Muller JM; Waschek JA
    J Biol Chem; 1998 Jul; 273(31):19685-90. PubMed ID: 9677397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pituitary adenylate cyclase-activating polypeptides directly stimulate sympathetic neuron neuropeptide Y release through PAC(1) receptor isoform activation of specific intracellular signaling pathways.
    Braas KM; May V
    J Biol Chem; 1999 Sep; 274(39):27702-10. PubMed ID: 10488112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. G-protein-coupled receptor kinase 3- and protein kinase C-mediated desensitization of the PACAP receptor type 1 in human Y-79 retinoblastoma cells.
    Dautzenberg FM; Hauger RL
    Neuropharmacology; 2001 Mar; 40(3):394-407. PubMed ID: 11166332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) on the spontaneous release of acetylcholine from the rat hippocampus by brain microdialysis.
    Masuo Y; Matsumoto Y; Tokito F; Tsuda M; Fujino M
    Brain Res; 1993 May; 611(2):207-15. PubMed ID: 8334515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated cyclic AMP synthesis in rat cerebral cortical slices: interaction with noradrenaline, adrenaline, and forskolin.
    Nowak JZ; Kuba K
    J Mol Neurosci; 2002; 18(1-2):47-52. PubMed ID: 11931349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions.
    Shivers BD; Görcs TJ; Gottschall PE; Arimura A
    Endocrinology; 1991 Jun; 128(6):3055-65. PubMed ID: 2036976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig.
    Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB
    Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor.
    Delporte C; Poloczek P; de Neef P; Vertongen P; Ciccarelli E; Svoboda M; Herchuelz A; Winand J; Robberecht P
    Mol Cell Endocrinol; 1995 Jan; 107(1):71-6. PubMed ID: 7796937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The stimulatory effects and binding characteristics of PACAP27 in rat dispersed pancreatic acini.
    Kashimura J; Shimosegawa T; Iguchi K; Mochizuki T; Yanaihara N; Koizumi M; Toyota T
    Tohoku J Exp Med; 1993 Nov; 171(3):243-54. PubMed ID: 7512757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages.
    Chedeville A; Mirossay L; Chastre E; Hurbain-Kosmath I; Lopez M; Gespach C
    FEBS Lett; 1993 Mar; 319(1-2):171-6. PubMed ID: 8384124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pituitary adenylate cyclase activating peptide and vasoactive intestinal polypeptide: differentiation effects on human neuroblastoma NB-OK-1 cells.
    Hoshino M; Li M; Zheng LQ; Suzuki M; Mochizuki T; Yanaihara N
    Neurosci Lett; 1993 Sep; 159(1-2):35-8. PubMed ID: 7903438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).
    Taupenot L; Mahata SK; Wu H; O'Connor DT
    J Clin Invest; 1998 Feb; 101(4):863-76. PubMed ID: 9466982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localization and characterization of PACAP receptors in the rat cerebellum during development: evidence for a stimulatory effect of PACAP on immature cerebellar granule cells.
    Basille M; Gonzalez BJ; Leroux P; Jeandel L; Fournier A; Vaudry H
    Neuroscience; 1993 Nov; 57(2):329-38. PubMed ID: 8115042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Signaling mechanisms underlying the insulinotropic effect of pituitary adenylate cyclase-activating polypeptide in HIT-T15 cells.
    Klinteberg KA; Karlsson S; Ahrén B
    Endocrinology; 1996 Jul; 137(7):2791-8. PubMed ID: 8770899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.
    Zhang W; Duan W; Cheung NS; Huang Z; Shao K; Li QT
    J Neurochem; 2007 Nov; 103(3):1157-67. PubMed ID: 17680996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pituitary adenylate cyclase-activating polypeptide regulation of AtT-20/D16v corticotrope cell proopiomelanocortin expression and secretion.
    Braas KM; Brandenburg CA; May V
    Endocrinology; 1994 Jan; 134(1):186-95. PubMed ID: 8275932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages.
    Pozo D; Delgado M; Martinez C; Gomariz RP; Guerrero JM; Calvo JR
    Biochim Biophys Acta; 1997 Dec; 1359(3):250-62. PubMed ID: 9434131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.